Spyre Therapeutics, Inc. Balance Sheet

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Accumulated Depreciation 0.11M0.24M0.49M0.75M1.05M1.98M2.80M4.14M
Receivables - Accured 0.30M0.20M0.10M0.10M0.90M3.40M
Assets
Assets 38.65M67.06M56.08M77.74M83.18M161.62M109.93M71.14M341.86M608.48M
Current Assets
Cash & Equivalents 2.62M29.29M47.75M12.82M22.46M19.25M90.09M15.14M34.86M188.89M89.42M
Receivables - Net 1.70M5.90M
Receivables - Other 1.70M1.22M3.08M0.81M0.38M
Receivables 3.40M5.90M
Prepaid Assets 0.91M1.71M1.61M2.16M2.56M3.52M4.95M6.17M2.25M5.39M
Current Assets 38.29M66.42M54.99M76.67M74.50M149.79M98.89M62.26M341.53M608.47M
Non-Current Assets
Property, Plant & Equipment (Net) 0.35M0.60M0.85M1.02M2.38M5.64M4.55M3.22M
Long-Term Deferred Tax 0.57M
Other Non-Current Assets 0.08M0.04M0.23M0.05M1.50M1.84M1.84M1.55M0.32M0.01M
Non-Current Assets 0.37M0.64M1.09M1.07M8.68M11.83M11.04M8.89M0.33M0.01M
Liabilities
Current Liabilities
Accounts Payables 0.18M0.17M0.39M0.66M3.15M2.25M3.32M0.68M16.58M0.67M
Payables 0.18M0.17M0.39M0.66M3.15M2.25M3.32M0.68M16.58M0.67M
Accumulated Expenses 2.35M3.73M5.22M9.58M14.85M13.87M14.03M12.84M13.11M27.71M
Other Accumulated Expenses 0.05M0.23M0.16M0.13M0.47M0.46M0.78M0.33M0.49M0.50M
Short term Debt 1.39M25.08M
Current Leases 0.35M0.32M0.44M0.62M
Current Deferred Revenue 0.07M0.02M2.36M2.70M
Total Current Liabilities 2.52M3.96M5.63M10.24M18.36M16.44M20.14M14.66M31.98M54.06M
Non-Current Liabilities
Non-Current Deffered Revenue 1.22M2.18M
Preferred Stock Liabilities 13.35M44.74M84.56M
Operating Leases 4.71M5.13M4.61M4.00M
Other Non-Current Liabilities 0.03M0.13M0.11M0.07M0.03M0.21M0.02M41.31M36.62M
Total Non-Current Liabilities 2.52M3.96M5.63M10.24M23.07M21.57M25.97M31.98M54.06M
Liabilities
Total Liabilities 11.47M2.55M4.10M5.74M10.31M23.10M21.79M25.98M20.84M73.29M90.68M
Shareholder's Equity
Total Debt 1.39M25.08M
Common Equity -11.47M-22.21M62.97M50.34M67.43M60.08M139.83M83.94M50.30M184.02M517.80M
Shareholder's Equity -11.47M-22.21M62.97M50.34M67.43M60.08M139.83M83.94M50.30M184.02M517.80M
Liabilities and Shareholders Equity 38.65M67.06M56.08M77.74M83.18M161.62M109.93M71.14M341.86M608.48M
Retained Earnings -23.58M-45.28M-72.51M-116.86M-195.12M-276.01M-341.81M-425.62M-764.41M-972.43M
Preferred Shares 184.93M146.43M
Treasury Shares 0.12M0.08M0.03M0.01M0.23M0.19M0.01M0.15M0.12M
Shares Outstanding 0.35M0.76M13.43M16.67M24.14M29.08M47.96M1.97M2.61M36.06M